New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Microplastics: Small Particles, Big Problem?
- Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease.
- Rutgers Office for Research Using Data to Inform and Improve the Rutgers Research Enterprise.
- Structural Racism and Public Health – AJPH Supplement
- NJACTS Community Engagement Core COVID-19 Resources